Skip to content
10-Q

Quarterly Report

HUMAN GENOME SCIENCES INC

0001193125-11-285088

← back to feed
Filed
Oct 28, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Sep 30, 2011 198.66M sh
Stock Repurchased Q3 2011 · Sep 30, 2011 $1.04M
Stock Repurchased Q3 2011 · Sep 30, 2010 $1.03M
Capex Q3 2011 · Sep 30, 2011 $11.49M
Capex Q3 2011 · Sep 30, 2010 $6.32M
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$315.84M
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$202.18M
Cash And Equivalents Q3 2011 · Sep 30, 2011 $37.66M
Cash And Equivalents Q3 2011 · Dec 31, 2010 $155.69M
Cash And Equivalents Q3 2011 · Sep 30, 2010 $230.36M
Cash And Equivalents Q3 2011 · Dec 31, 2009 $567.67M
Stockholders Equity Q3 2011 · Sep 30, 2011 $448.8M
Stockholders Equity Q3 2011 · Dec 31, 2010 $585.76M
Current Liabilities Q3 2011 · Sep 30, 2011 $384.48M
Current Liabilities Q3 2011 · Dec 31, 2010 $280.94M
Total Liabilities Q3 2011 · Sep 30, 2011 $648.48M
Total Liabilities Q3 2011 · Dec 31, 2010 $729.27M
Current Assets Q3 2011 · Sep 30, 2011 $655.98M
Current Assets Q3 2011 · Dec 31, 2010 $531.18M
Total Assets Q3 2011 · Sep 30, 2011 $1.1B
Total Assets Q3 2011 · Dec 31, 2010 $1.32B
Rd Expense Q3 2011 · Sep 30, 2011 $38.76M
Rd Expense Q3 2011 · Sep 30, 2011 $156.65M
Rd Expense Q3 2011 · Sep 30, 2010 $42.47M
Rd Expense Q3 2011 · Sep 30, 2010 $151.33M
Net Income Q3 2011 · Sep 30, 2011 −$88.43M
Net Income Q3 2011 · Sep 30, 2011 −$300.08M
Net Income Q3 2011 · Sep 30, 2010 −$40.86M
Net Income Q3 2011 · Sep 30, 2010 −$145.6M
Operating Income Q3 2011 · Sep 30, 2011 −$76M
Operating Income Q3 2011 · Sep 30, 2011 −$260.49M
Operating Income Q3 2011 · Sep 30, 2010 −$29.83M
Operating Income Q3 2011 · Sep 30, 2010 −$114.59M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $12.42M
Cost Of Revenue Q3 2011 · Sep 30, 2011 $34.03M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $8.43M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $23.53M
Revenue Q3 2011 · Sep 30, 2011 $34.02M
Revenue Q3 2011 · Sep 30, 2011 $85.45M
Revenue Q3 2011 · Sep 30, 2010 $50.78M
Revenue Q3 2011 · Sep 30, 2010 $136.09M